Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients

Background and Objectives: Even though low-molecular-weight heparin (LMWH), including dalteparin, has a critical role in portal vein thrombosis (PVT) treatment in liver cirrhosis (LC) patients, the predictive factors and the proper dose of dalteparin for PVT treatment and relapse have not yet been i...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ji Min, Koh, Youngil, Kim, Sung Hwan, Suh, Sung Yun, Cho, Yoon Sook, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Gwak, Hye Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965161/
https://www.ncbi.nlm.nih.gov/pubmed/36837493
http://dx.doi.org/10.3390/medicina59020292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965161/
https://www.ncbi.nlm.nih.gov/pubmed/36837493
http://dx.doi.org/10.3390/medicina59020292

Ejemplares similares